| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.083 | 0.005 |